FAM9B
geneOn this page
Also known as TEX39B
Summary
FAM9B (family with sequence similarity 9 member B, HGNC:18404) is a protein-coding gene on chromosome Xp22.31, encoding Protein FAM9B (Q8IZU0). May play a role in meiosis.
This gene is a member of a gene family which arose through duplication on the X chromosome. The encoded protein may be localized to the nucleus as the protein contains several nuclear localization signals, and has similarity to a synaptonemal complex protein.
Source: NCBI Gene 171483 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 40 total — 1 pathogenic
- MANE Select transcript:
NM_205849
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18404 |
| Approved symbol | FAM9B |
| Name | family with sequence similarity 9 member B |
| Location | Xp22.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TEX39B |
| Ensembl gene | ENSG00000177138 |
| Ensembl biotype | protein_coding |
| OMIM | 300478 |
| Entrez | 171483 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000327220, ENST00000362066, ENST00000428477, ENST00000461107, ENST00000472522, ENST00000494744, ENST00000651278
RefSeq mRNA: 1 — MANE Select: NM_205849
NM_205849
CCDS: CCDS14132
Canonical transcript exons
ENST00000327220 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001433882 | 9033852 | 9034127 |
| ENSE00001897452 | 9024232 | 9025377 |
| ENSE00003466809 | 9032959 | 9033075 |
| ENSE00003472429 | 9025484 | 9025583 |
| ENSE00003522410 | 9027868 | 9027966 |
| ENSE00003634219 | 9032130 | 9032161 |
| ENSE00003659377 | 9032341 | 9032461 |
| ENSE00003682132 | 9029307 | 9029418 |
| ENSE00003693246 | 9030261 | 9030360 |
Expression profiles
Bgee: expression breadth broad, 74 present calls, max score 80.93.
Top tissues by expression
216 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.93 | gold quality |
| right lobe of liver | UBERON:0001114 | 72.80 | gold quality |
| right testis | UBERON:0004534 | 72.78 | gold quality |
| left testis | UBERON:0004533 | 72.12 | gold quality |
| testis | UBERON:0000473 | 71.52 | gold quality |
| buccal mucosa cell | CL:0002336 | 68.10 | gold quality |
| body of uterus | UBERON:0009853 | 67.17 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.46 | gold quality |
| liver | UBERON:0002107 | 61.77 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 61.01 | gold quality |
| myometrium | UBERON:0001296 | 55.63 | gold quality |
| uterus | UBERON:0000995 | 53.17 | gold quality |
| stromal cell of endometrium | CL:0002255 | 51.58 | silver quality |
| prostate gland | UBERON:0002367 | 51.48 | gold quality |
| sural nerve | UBERON:0015488 | 51.35 | gold quality |
| endometrium | UBERON:0001295 | 49.87 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.63 | gold quality |
| granulocyte | CL:0000094 | 47.96 | silver quality |
| hypothalamus | UBERON:0001898 | 45.59 | gold quality |
| female reproductive system | UBERON:0000474 | 44.66 | gold quality |
| oocyte | CL:0000023 | 43.92 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| monocyte | CL:0000576 | 43.15 | silver quality |
| corpus epididymis | UBERON:0004359 | 42.98 | gold quality |
| adult organism | UBERON:0007023 | 42.85 | gold quality |
| blood | UBERON:0000178 | 42.83 | gold quality |
| muscle tissue | UBERON:0002385 | 42.70 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| quadriceps femoris | UBERON:0001377 | 42.39 | gold quality |
| lymph node | UBERON:0000029 | 42.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting FAM9B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-377-5P | 99.70 | 65.28 | 712 |
| HSA-MIR-6086 | 99.70 | 65.38 | 699 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-5689 | 99.50 | 71.26 | 1154 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-18A-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-18B-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
Literature-anchored findings (GeneRIF, showing 1)
- Expressed exclusively in testis; protein is located in the nucleus. (PMID:12213195)
Cross-species orthologs
21 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sycp3 | ENSDARG00000013438 |
| mus_musculus | Xlr4c | ENSMUSG00000031362 |
| mus_musculus | Xlr3a | ENSMUSG00000057836 |
| mus_musculus | Xlr3c | ENSMUSG00000058147 |
| mus_musculus | Xlr5a | ENSMUSG00000058328 |
| mus_musculus | Xlr5c | ENSMUSG00000067764 |
| mus_musculus | Xlr4b | ENSMUSG00000067768 |
| mus_musculus | Xlr5b | ENSMUSG00000072479 |
| mus_musculus | Xlr3b | ENSMUSG00000073125 |
| mus_musculus | Gm14692 | ENSMUSG00000079577 |
| mus_musculus | Gm1140 | ENSMUSG00000079578 |
| mus_musculus | Xlr4a | ENSMUSG00000079845 |
| rattus_norvegicus | Xlr5c | ENSRNOG00000050177 |
| rattus_norvegicus | Xlr4a | ENSRNOG00000055822 |
| rattus_norvegicus | Fam9cl1 | ENSRNOG00000062315 |
| rattus_norvegicus | LOC100911047 | ENSRNOG00000064693 |
| rattus_norvegicus | LOC100911047 | ENSRNOG00000068104 |
| rattus_norvegicus | Fam9c | ENSRNOG00000069253 |
| rattus_norvegicus | ENSRNOG00000075733 | |
| rattus_norvegicus | ENSRNOG00000087898 | |
| rattus_norvegicus | ENSRNOG00000088563 |
Paralogs (3): SYCP3 (ENSG00000139351), FAM9A (ENSG00000183304), FAM9C (ENSG00000187268)
Protein
Protein identifiers
Protein FAM9B — Q8IZU0 (reviewed: Q8IZU0)
All UniProt accessions (1): Q8IZU0
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in meiosis.
Subcellular location. Nucleus. Cytoplasm. Chromosome.
Tissue specificity. Expressed in testis and ovary (at protein level).
Similarity. Belongs to the XLR/SYCP3 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IZU0-1 | 1 | yes |
| Q8IZU0-2 | 2 |
RefSeq proteins (1): NP_995321* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006888 | XLR/SYCP3/FAM9_dom | Domain |
| IPR051443 | XLR/SYCP3 | Family |
Pfam: PF04803
UniProt features (7 total): compositionally biased region 3, splice variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZU0-F1 | 79.88 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE, GOCC_NUCLEAR_CHROMOSOME, GOCC_CONDENSED_NUCLEAR_CHROMOSOME, SENESE_HDAC1_AND_HDAC2_TARGETS_UP, chrXp22, GOCC_SYNAPTONEMAL_STRUCTURE, DIDO1_TARGET_GENES, HES2_TARGET_GENES, MAFG_TARGET_GENES, MIR4778_3P, MIR6740_3P, MIR18A_5P_MIR18B_5P
GO Biological Process (2): spermatid development (GO:0007286), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): synaptonemal complex (GO:0000795), nucleus (GO:0005634), nucleoplasm (GO:0005654), chromosome (GO:0005694), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| synaptonemal structure | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
736 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM9B | Q15513 | Q15513 | 518 |
| FAM9B | SHBG | P04278 | 446 |
| FAM9B | NUTM2F | A1L443 | 431 |
| FAM9B | ST8SIA5 | O15466 | 421 |
| FAM9B | IZUMO3 | Q5VZ72 | 415 |
| FAM9B | JMJD1C | Q15652 | 414 |
| FAM9B | FAM47C | Q5HY64 | 398 |
| FAM9B | ST6GALNAC4 | Q9H4F1 | 387 |
| FAM9B | CPXCR1 | Q8N123 | 374 |
| FAM9B | ANOS1 | P23352 | 370 |
| FAM9B | CMC4 | P56277 | 369 |
| FAM9B | VCX3B | Q9H321 | 358 |
| FAM9B | ATP6V0D1 | P12953 | 353 |
| FAM9B | AGRP | O00253 | 353 |
| FAM9B | ADAT1 | Q9BUB4 | 333 |
IntAct
507 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM9B | XRCC4 | psi-mi:“MI:0915”(physical association) | 0.870 |
| XRCC4 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.870 |
| PRPF3 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.810 |
| FAM9B | PRPF3 | psi-mi:“MI:0915”(physical association) | 0.810 |
| FAM9B | PHYH | psi-mi:“MI:0915”(physical association) | 0.780 |
| FAM9B | SMN1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| FAM9B | CCDC106 | psi-mi:“MI:0915”(physical association) | 0.780 |
| FAM9B | CHRAC1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SMN1 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.780 |
| HAPSTR1 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.740 |
| SDCBP | FAM9B | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM9B | NDUFB10 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM9B | SLPI | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM9B | SDCBP | psi-mi:“MI:0915”(physical association) | 0.720 |
| SLPI | FAM9B | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM9B | FCHSD2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TUFM | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM9B | FASTKD3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TGFBI | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM9B | SNX20 | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM9B | MYG1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CDC42EP4 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
| CEP95 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM9B | FERD3L | psi-mi:“MI:0915”(physical association) | 0.670 |
| SYT17 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
BioGRID (188): FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid), FAM9B (Two-hybrid)
ESM2 similar proteins: A7TJT3, B3EWV0, C0HLQ3, O31159, O66093, O66096, O91083, P0C1J9, P0C1K3, P0C1K4, P0C8M3, P0CA74, P21016, P24360, P33868, P52531, P80745, P82331, P83602, P84712, P86298, P86299, P86300, P86301, P86302, P86305, P86307, P86309, P86310, P86688, Q02838, Q1A264, Q27976, Q44160, Q46490, Q54C30, Q54KW6, Q54PY5, Q54V15, Q54X31
Diamond homologs: P05531, P70281, Q3T0E2, Q4R764, Q60547, Q60595, Q61806, Q63520, Q6P205, Q8IZU0, Q8IZU3, Q8IZT9, Q8IZU1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 816281 | GRCh37/hg19 Xp22.33-22.12(chrX:1240318-20986848)x2 | Pathogenic |
SpliceAI
953 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:9027963:TTCT:T | acceptor_gain | 1.0000 |
| X:9027965:CT:C | acceptor_gain | 1.0000 |
| X:9027967:C:CC | acceptor_gain | 1.0000 |
| X:9027976:C:T | acceptor_gain | 1.0000 |
| X:9029302:CCAA:C | donor_gain | 1.0000 |
| X:9029305:A:AC | donor_gain | 1.0000 |
| X:9029306:C:CC | donor_gain | 1.0000 |
| X:9029306:CA:C | donor_gain | 1.0000 |
| X:9029306:CAA:C | donor_gain | 1.0000 |
| X:9029317:T:TA | donor_gain | 1.0000 |
| X:9029318:C:A | donor_gain | 1.0000 |
| X:9029326:C:CA | donor_gain | 1.0000 |
| X:9029341:T:TA | donor_gain | 1.0000 |
| X:9029415:CTGC:C | acceptor_gain | 1.0000 |
| X:9029416:TGC:T | acceptor_gain | 1.0000 |
| X:9029417:GC:G | acceptor_gain | 1.0000 |
| X:9029418:CC:C | acceptor_gain | 1.0000 |
| X:9029419:C:CC | acceptor_gain | 1.0000 |
| X:9029419:C:CG | acceptor_loss | 1.0000 |
| X:9029420:T:A | acceptor_loss | 1.0000 |
| X:9030370:CAGT:C | acceptor_gain | 1.0000 |
| X:9030371:A:T | acceptor_gain | 1.0000 |
| X:9030373:T:C | acceptor_gain | 1.0000 |
| X:9030373:T:TC | acceptor_gain | 1.0000 |
| X:9030377:A:AC | acceptor_gain | 1.0000 |
| X:9030380:G:GC | acceptor_gain | 1.0000 |
| X:9030384:A:AC | acceptor_gain | 1.0000 |
| X:9032329:TAA:T | donor_gain | 1.0000 |
| X:9032330:AAA:A | donor_gain | 1.0000 |
| X:9032335:CTTTA:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001299967 (X:9023944 C>T), RS1001351418 (X:9034481 T>G), RS1001585686 (X:9024291 G>A,C), RS1003524488 (X:9026454 G>A), RS1005544430 (X:9031827 C>T), RS1005670166 (X:9027005 G>A,T), RS1005957421 (X:9024682 T>C), RS1006032211 (X:9026513 G>A), RS1006126546 (X:9034636 A>G,T), RS1006449729 (X:9035867 C>A), RS1006552655 (X:9035283 T>A,C), RS1007504537 (X:9033922 C>T), RS1007651407 (X:9036006 G>A), RS1007824024 (X:9034171 G>A,C), RS1007923571 (X:9025218 G>A)
Disease associations
OMIM: gene MIM:300478 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001653_4 | Androgen levels | 2.000000e-08 |
| GCST003983_43 | Male-pattern baldness | 4.000000e-08 |
| GCST003994_14 | Age at voice drop | 3.000000e-09 |
| GCST005116_57 | Male-pattern baldness | 4.000000e-13 |
| GCST005984_21 | Glomerular filtration rate | 5.000000e-09 |
| GCST005985_11 | Creatinine levels | 5.000000e-09 |
| GCST005994_15 | Hematocrit | 3.000000e-08 |
| GCST005995_5 | Hemoglobin | 4.000000e-08 |
| GCST006288_418 | Heel bone mineral density | 5.000000e-17 |
| GCST006288_698 | Heel bone mineral density | 6.000000e-07 |
| GCST006979_838 | Heel bone mineral density | 1.000000e-24 |
| GCST009391_1044 | Metabolite levels | 2.000000e-07 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004908 | testosterone measurement |
| EFO:0007888 | age at voice drop |
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| bufotalin | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): androgenetic alopecia